Last 48 quarters of trend data · Healthcare · Medical Supplies & Consumables
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -18.55 | 10.53 | 22.21 | — | — | — | 42.06 | 34.23 | — | 35.16 | — | 147.18 | 20.14 | 1.91 | — | 112.67 | 35.40 | — | 32.12 | 138.46 | 45.66 |
| — | — | -47.2% | — | — | — | — | -76.7% | — | +1737.1% | — | +30.6% | -43.1% | — | — | -18.6% | -22.5% | — | -5.8% | +280.9% | -24.9% | |
| P/S Ratio | 1.15 | 1.05 | 0.93 | 0.80 | 0.83 | 1.03 | 1.38 | 1.68 | 1.35 | 1.80 | 1.58 | 2.19 | 1.26 | 1.84 | 1.55 | 1.46 | 1.66 | 1.88 | 2.27 | 2.66 | 3.10 |
| — | +1.6% | -32.6% | -52.2% | -38.9% | -42.7% | -12.5% | -23.4% | +7.1% | -2.2% | +1.8% | +49.5% | -24.1% | -2.1% | -31.5% | -45.0% | -46.3% | -40.4% | -31.4% | -27.2% | -4.8% | |
| P/B Ratio | 2.17 | 1.93 | 1.79 | 1.44 | 1.61 | 1.62 | 2.13 | 2.49 | 2.12 | 2.45 | 2.21 | 2.65 | 2.31 | 2.34 | 4.09 | 3.46 | 4.38 | 4.87 | 3.66 | 4.33 | 4.77 |
| — | +18.8% | -16.2% | -42.3% | -24.0% | -33.7% | -3.6% | -5.8% | -8.5% | +4.5% | -45.9% | -23.5% | -47.2% | -51.8% | +11.7% | -20.0% | -8.1% | +5.4% | -23.7% | -14.7% | +0.6% | |
| P/FCF | 13.32 | 6.96 | 86.28 | 28.46 | 5.53 | 23.22 | 57.22 | — | 10.59 | 21.22 | — | 102.82 | 14.37 | 13.59 | 30.66 | 16.53 | 27.03 | 52.61 | 59.54 | 145.10 | 23.76 |
| — | -70.0% | +50.8% | — | -47.8% | +9.4% | — | — | -26.3% | +56.2% | — | +522.0% | -46.8% | -74.2% | -48.5% | -88.6% | +13.8% | +156.5% | +85.4% | +177.4% | +9.0% | |
| EV / EBITDA | 28.55 | 10.10 | 10.18 | 13.47 | — | 12.04 | 13.17 | 20.99 | — | 19.08 | 17.43 | 21.34 | 11.73 | 27.93 | 32.09 | 20.24 | 15.04 | — | 19.74 | 25.26 | 23.44 |
| — | -16.1% | -22.7% | -35.8% | — | -36.9% | -24.4% | -1.6% | — | -31.7% | -45.7% | +5.4% | -22.0% | — | +62.6% | -19.9% | -35.8% | — | +14.7% | +31.9% | +30.5% | |
| EV / EBIT | — | 10.10 | 19.75 | 68.01 | — | 26.04 | 28.78 | 82.08 | — | 45.90 | 32.02 | 55.27 | 21.57 | 37.84 | — | 63.44 | 29.60 | — | 38.41 | 75.35 | 40.78 |
| — | -61.2% | -31.4% | -17.1% | — | -43.3% | -10.1% | +48.5% | — | +21.3% | — | -12.9% | -27.1% | — | — | -15.8% | -27.4% | — | +48.2% | +151.6% | -8.0% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 30.1% | 33.4% | 34.9% | 33.0% | 19.4% | 33.5% | 35.3% | 32.8% | 34.8% | 38.3% | 38.3% | 38.6% | 37.9% | 40.6% | 30.0% | 36.3% | 37.6% | 29.0% | 38.1% | 36.4% | 40.0% |
| — | -0.3% | -1.1% | +0.6% | -44.3% | -12.4% | -7.8% | -15.0% | -8.1% | -5.8% | +27.7% | +6.3% | +0.7% | +40.3% | -21.4% | -0.2% | -5.9% | -29.3% | -4.2% | -6.4% | +6.9% | |
| Operating Margin | -2.7% | 7.6% | 7.3% | 2.4% | -24.5% | 6.1% | 6.8% | 2.2% | -15.8% | 5.7% | 6.6% | 4.6% | 8.5% | 6.9% | -0.5% | 3.7% | 9.1% | -79.8% | 7.3% | 4.4% | 10.9% |
| — | +24.6% | +7.9% | +10.6% | -55.1% | +5.6% | +2.3% | -52.2% | -286.6% | -16.6% | +1548.8% | +25.8% | -6.8% | +108.6% | -106.2% | -16.5% | -16.7% | -601.8% | -46.3% | -66.8% | -14.6% | |
| Net Margin | -8.5% | 9.9% | 4.3% | -0.6% | -37.9% | -1.6% | 3.2% | 4.8% | -18.6% | 5.2% | -11.7% | 1.5% | 6.3% | 96.5% | -3.8% | 1.3% | 4.7% | -81.4% | 7.0% | 1.9% | 6.8% |
| — | +708.8% | +31.4% | -111.6% | -103.9% | -131.3% | +127.8% | +223.0% | -394.9% | -94.6% | -206.4% | +18.6% | +35.4% | +218.6% | -154.2% | -34.6% | -31.2% | -683.4% | -27.1% | -81.1% | +28.2% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -14.6% | 4.6% | 2.1% | -0.2% | -16.9% | -0.6% | 1.3% | 1.8% | -6.8% | 1.8% | -3.9% | 0.4% | 2.9% | 36.4% | -2.4% | 0.7% | 3.2% | -40.6% | 2.8% | 0.8% | 2.7% |
| — | +832.7% | +62.9% | -113.8% | -147.6% | -135.4% | +132.2% | +304.1% | -332.3% | -95.1% | -61.6% | -40.4% | -6.6% | +189.6% | -187.1% | -4.5% | +18.9% | -881.9% | -20.1% | -77.5% | +36.9% | |
| ROA | -4.2% | 1.5% | 0.6% | -0.1% | -5.5% | -0.2% | 0.4% | 0.5% | -2.0% | 0.5% | -1.2% | 0.1% | 0.8% | 8.6% | -0.5% | 0.2% | 0.6% | -9.8% | 0.8% | 0.2% | 0.9% |
| — | +786.4% | +47.9% | -114.1% | -181.1% | -141.4% | +137.0% | +305.5% | -334.8% | -93.8% | -131.2% | -15.1% | +29.2% | +187.2% | -164.3% | -27.5% | -27.9% | -531.0% | -48.7% | -85.8% | +6.6% | |
| ROIC | -1.4% | 1.2% | 1.2% | 0.4% | -3.8% | 0.8% | 0.9% | 0.3% | -1.7% | 0.6% | 0.7% | 0.4% | 1.3% | 0.7% | -0.1% | 0.5% | 1.3% | -9.6% | 0.8% | 0.5% | 1.6% |
| — | +47.9% | +26.1% | +39.2% | -121.2% | +40.6% | +34.6% | -41.9% | -233.5% | -10.1% | +1253.9% | -2.5% | +1.5% | +107.0% | -107.5% | -8.9% | -20.4% | -399.3% | -69.4% | -79.8% | -40.5% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.64 | 1.36 | 1.56 | 1.61 | 1.60 | 1.35 | 1.33 | 1.46 | 1.91 | 1.66 | 1.73 | 1.72 | 1.67 | 2.07 | 3.00 | 2.84 | 2.92 | 3.03 | 1.93 | 1.94 | 2.01 |
| — | +1.0% | +17.3% | +10.2% | -16.3% | -19.0% | -23.0% | -15.1% | +14.9% | -19.9% | -42.4% | -39.5% | -42.9% | -31.5% | +55.9% | +46.6% | +45.4% | +314.3% | +147.8% | +151.0% | +157.5% | |
| Debt / EBITDA | 14.86 | 18.42 | 21.20 | 31.97 | — | 23.75 | 21.71 | 33.80 | — | 32.26 | 32.86 | 36.71 | 21.61 | 62.47 | 56.78 | 38.21 | 25.04 | — | 28.26 | 32.56 | 29.16 |
| — | -22.4% | -2.3% | -5.4% | — | -26.4% | -33.9% | -7.9% | — | -48.4% | -42.1% | -3.9% | -13.7% | — | +100.9% | +17.3% | -14.1% | — | +175.1% | +201.3% | +165.2% | |
| Current Ratio | 2.31 | 1.79 | 1.95 | 1.85 | 2.31 | 1.84 | 2.30 | 2.02 | 1.36 | 1.43 | 1.40 | 1.48 | 1.48 | 1.94 | 1.42 | 1.70 | 1.69 | 2.11 | 2.01 | 2.10 | 2.09 |
| — | -2.4% | -15.2% | -8.3% | +70.2% | +28.5% | +63.8% | +36.8% | -7.9% | -26.2% | -1.5% | -13.2% | -12.6% | -8.0% | -29.3% | -19.0% | -19.4% | -11.3% | -15.9% | -14.8% | -17.0% | |
| Quick Ratio | 1.56 | 1.19 | 1.32 | 1.23 | 1.56 | 1.18 | 1.49 | 1.40 | 1.05 | 1.09 | 0.91 | 1.01 | 1.18 | 1.48 | 0.92 | 1.09 | 1.12 | 1.38 | 1.33 | 1.45 | 1.52 |
| — | +0.3% | -11.3% | -12.2% | +49.4% | +8.7% | +62.4% | +38.7% | -11.5% | -26.1% | -0.7% | -7.4% | +5.1% | +6.5% | -30.9% | -24.8% | -25.8% | -22.4% | -25.0% | -21.1% | -22.2% | |
| Interest Coverage | -0.74 | 7.84 | 3.05 | 0.77 | -9.96 | 2.78 | 2.85 | 0.96 | -4.21 | 1.68 | 2.13 | 1.45 | 3.03 | 1.47 | -0.39 | 1.11 | 2.79 | -26.94 | 3.35 | 2.07 | 4.63 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying BAX stock.
Baxter International Inc.'s current P/E is -18.5x. The average P/E over the last 2 quarters is 16.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Baxter International Inc.'s current operating margin is -2.7%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Baxter International Inc.'s business trajectory between earnings reports.